GlassScriptPhysician profile
Michael N Neilson
NPI 1386056752
$1,931.24
in general payments reported to CMS, 2019-2025
15 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,164 · 2020: $89.46 · 2021: $195 · 2022: $248 · 2023: $31.63 · 2024: $47.38 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $771.35 | 2019-2022 | |
| Boston Scientific Corporation | $314.54 | 2021-2025 | Varithena Administration Pack |
| Cook Medical LLC | $303.03 | 2019 | |
| Endologix LLC | $117.59 | 2019 | |
| Bard Peripheral Vascular, INC. | $95.73 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $87.25 | 2022-2025 | Gore Tag Conformable Thoracic Stent Graft |
| Shockwave Medical, INC | $37.53 | 2025 | |
| Medtronic, INC. | $29.99 | 2022-2025 | Hawkone |
| Getinge USA Sales, LLC | $27.60 | 2021 | |
| Silk Road Medical, INC. | $26.78 | 2021 | |
| Convatec INC. | $26.67 | 2020 | |
| Cordis US Corp. | $23.91 | 2024 | Brite Tip Radianz |
| Abbott Laboratories | $23.72 | 2025 | Emboshield Nav6 |
| Mimedx Group, INC. | $23.47 | 2024 | |
| Smith+Nephew, INC. | $22.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Neilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.